How to reach high plasma protein concentration with single-pass TFF

Historically MSI has been used to screen for Lynch syndrome, a dominant hereditary cancer propensity. Since 2015, MSI status has been rediscovered as a biomarker for immunotherapeutic response

Among many exciting precision medicine strategies, RNA-based therapeutics are rapidly growing in popularity and effectiveness. Although progress has been achieved in developing RNA-targeted delivery carriers (mainly by using monoclonal antibodies for targeting), their clinical translation has yet to be fully recognized. This is due, in no small part, to massive development and production requirements and high batch-to-batch variability of current technologies, which currently rely on chemical conjugation. Novel synthesis methodologies could help vault these therapeutic strategies into the market and patients much more quickly.

Inflammasomes are a family of proteins that activate inflammatory cytokines and help to both control infections and contribute to disease pathology.

The Webinar will focus on how health sciences are becoming more democratized and decentralized, hacking biotechnology investments is getting more accessible, obvious, and transparent. Investing in biotech is no longer reserved for specialized VCs and funds with deep pockets. This one hour webinar will discuss finding the right opportunities in responsible healthcare investing, focusing on investing in biotech companies.